Navigation Links
China Haemophilus Influenza B (HIB) Vaccine Market 2017 Forecasts in New Research Now Available at MarketReportsOnline.com
Date:9/23/2013

Dallas, Texas (PRWEB) September 23, 2013

At present, there is still no national statistical data on HIB diseases in China. According to a large scale epidemiology investigation held in Hefei, the incidence rate of HIB meningitis was 107/100,000,000 among children below five years old in Hefei and the fatality rate was 9.7%. After treated, 21.4% survival children still suffer nervous or nervous system complications or sequelae. According to the epidemiology investigation in Hefei, CRI predicts that the incidence rate of HIB invasive meningitis is 104/100,000,000 among children below five years old. However, the incidence rate of HIB diseases among all people is still not clear.

HIB vaccines still belong to Vaccine II in China, so children are inoculated HIB vaccines at the expenses of their parents voluntarily. In 2012, China’s lot release volume of HIB vaccines was 32.4098 million doses, increasing by 34.84% YOY, with the market scale exceeding CNY 2 billion. As free vaccines that are widely applied in developed countries, HIB vaccines have extremely huge development space in China. Research Report on China's Haemophilus Influenza B (HIB) Vaccine Industry, 2013-2017 ( http://www.marketreportsonline.com/275802.html ) predicts that HIB vaccines are likely to become Vaccine I in the coming years.

Haemophilus influenza type B is a kind of haemophilus influenza with extremely strong invasiveness. Among all the serious infections caused by haemophilus influenzas, almost 90% were caused by haemophilus influenza type B. According to the researches in recent years, HIB has become the first bacteria that will cause diseases on the respiratory tracts of children in China. It mainly causes lower respiratory infection and pneumonia. After infected by HIB, the risk of getting invasive diseases is related to one’s HIB immune level. The prevalence rate of HIB antibody in infants is quite high, which mainly comes from mothers. Antibody titer reaches the highest point when infants are three to four months old. In addition, because infants are naturally exposed to HIB or other pathogenic bacteria, their antibody concentration will gradually increase in the early time. As a result, the incidence rate of HIB invasive diseases is quite low among newborns. However, along with the decline of antibody concentration, the incidence rate reaches the highest point in the middle childhood. In addition, the incidence rate gradually declines with immune system becoming increasingly complete. Therefore, HIB infection generally happens on children below five years old. More specifically, the incidence mainly happens to children below two years old. The distribution of HIB infection seasons shows a doublepeak in winter and autumn as one peak and spring as the other peak. Generally speaking, the incidence rate is the highest in winter and the lowest in summer.

The following enterprises and people are proposed to purchase this report available at http://www.marketreportsonline.com/contacts/purchase.php?name=275802 : Vaccine manufacturing enterprises, Medical institutions as well as Investors and research institutes concerned about China vaccine industry.

Through this report, readers can acquire the following information:

  •     Development environment of China HIB vaccine industry
  •     Epidemic situation of HIB diseases in China
  •     Supply and demand of HIB vaccines in China
  •     Major manufacturing enterprises in China HIB vaccine market
  •     Forecast on China HIB vaccine market, 20132017

Major Manufacturing Enterprises in China HIB Vaccine Market, analyzed in this report for the period 2010-2013, include Lanzhou Institute of Biological Products Co., Ltd., Sanofi Pasteur, GSK China and Novartis Vaccines and Diagnostics S.R.L.

List of Charts available in Research Report on China's Haemophilus Influenza B (HIB) Vaccine Industry, 2013-2017 (http://www.marketreportsonline.com/275802-toc.html ) include:

Chart Disposable Income Per Capita of Chinese Residents, 2008-2012
Chart Chinese Population Size, 2001-2012
Chart Chinese Newborn Population Size, 2001-2012
Chart Market Scale of China Vaccine Market, 2008-2012
Chart China's Lot Release Volume of HIB Conjugate Vaccines, 2010-2012
Chart Factory Prices of Major HIB Vaccines in China Market, 2013
Chart Market Scale of HIB Vaccines in China, 2010-2012
Chart Lot Release Volume of HIB Vaccines of Lanzhou Institute of Biological Products Co., Ltd., 2010-2012
Chart Lot Release Volume of HIB Vaccines of Walvax Biotechnology Co., Ltd., 2010-2012
Chart Forecast on Market Scale of HIB Vaccines in China, 2013-2017

Explore more reports on the Pharmaceutical market at http://www.marketreportsonline.com/cat/pharmaceuticals-market-research.html .

About Us:
MarketReportsOnline.com is an online database of regional industry research reports (http://www.marketreportsonline.com/latestreport.php ), company profiles and SWOT analysis studies for multiple industries and organizations. Our sales and research experts offer 24 X 7 support to our customers through phone and email communication. Not limited to the life sciences industry, MarketReportsOnline.com offers research studies on agriculture, chemicals, energy, power, environment, food and beverages, healthcare, medical devices and much more.

Read the full story at http://www.prweb.com/releases/china-hib-vaccine-market/haemophilus-influenza-b/prweb11150213.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Perfume Industry Review of Natural & Synthetic Perfumes for Global & China Markets in a New Research Study Available at DeepResearchReports.com
2. China Non-Small Cell Lung Cancer Analysis & 2022 Forecasts in New Research Report at RnRMarketResearch.com
3. China Human Rabies Vaccine Industry 2013 Analysis & 2017 Forecasts in New Research Report at RnRMarketResearch.com
4. 2013 China Medical Insurance Inflation Rates Revealed
5. China Poultry Vaccine Market Analysis
6. China Orthopedic Instrument Market 2013 Analysis & 2015 Forecasts in New Research Report at RnRMarketResearch.com
7. Medical Device Manufacturing in China Industry Research Report – Now Available from IBISWorld
8. China Independent Clinical Laboratory Industry Report, 2013-2015: Worldwide Industry Latest Market Share, Strategy, Growth, Size, Trends and Forecast Research Report 2015
9. Autonomous Clinical Laboratory Market in China 2013 Analysis & 2015 Forecasts in New Report Now Available at RnRMarketResearch.com
10. China BCAAs Market (Branched-Chain Amino Acids) Suppy & Forecasts in a New Research at ReportsnReports.com
11. Artisan Business Group Announces EB-5 China Trade Mission Itinerary
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... ... to revolutionize the emergency ambulance transport experience for the millions of people who ... Uber has disrupted the taxi industry through the use of technology. Now, SmartEMS ...
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A Forever Recovery, ... Festival and World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility ... home to some of the world’s leading providers of cereal and other breakfast foods. ...
(Date:6/26/2016)... ... , ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop a ... fitness app plans to fix the two major problems leading the fitness industry today:, ... type program , They don’t eliminate all the reasons people quit their exercise ...
(Date:6/25/2016)... ... 2016 , ... Austin residents seeking Mohs surgery services, can now turn to ... Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to ... fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) announced ... Act of 1976, as amended ("HSR"), with respect to ... CPXX ) expired effective June 24, 2016, ... previously announced on May 31, 2016, Jazz Pharmaceuticals and ... Jazz Pharmaceuticals has commenced a tender offer for all ...
(Date:6/26/2016)... 2016 Story Highlights: ... within the health care industry is causing providers to ... , Deloitte offers a suite of solutions for health ... efficient cost optimization: labor resource analysis, revenue cycle optimization ... better outcomes and better economics ...
(Date:6/24/2016)... , June 24, 2016  Collagen Matrix, ... design, development and manufacturing of collagen and mineral ... announced today that Bill Messer has ... Marketing to further leverage the growing portfolio of ... devices. Bill joins the Collagen Matrix ...
Breaking Medicine Technology: